Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,762,000 | 6,329,000 | 7,067,000 | 15,567,000 | 7,636,000 |
| Marketable Securities | 115,000 | 152,000 | 142,000 | 103,000 | 193,000 |
| Receivables | 9,050,000 | 10,307,000 | 8,854,000 | 6,842,000 | 6,628,000 |
| Inventories | 7,624,000 | 8,983,000 | 10,528,000 | 4,762,000 | 4,278,000 |
| Other current assets | 96,000 | 473,000 | 100,000 | 0 | 0 |
| TOTAL | $22,647,000 | $26,244,000 | $26,691,000 | $27,274,000 | $18,735,000 |
| Non-Current Assets | |||||
| PPE Net | 9,061,000 | 9,183,000 | 9,214,000 | 8,357,000 | 8,189,000 |
| Investments And Advances | 1,324,000 | 1,339,000 | 1,675,000 | 1,244,000 | 1,175,000 |
| Intangibles | 61,228,000 | 62,384,000 | 64,185,000 | 31,804,000 | 32,112,000 |
| Other Non-Current Assets | 6,013,000 | 6,213,000 | 5,456,000 | 4,962,000 | 4,715,000 |
| TOTAL | $77,626,000 | $79,119,000 | $80,530,000 | $46,367,000 | $46,191,000 |
| Total Assets | $100,273,000 | $105,363,000 | $107,221,000 | $73,641,000 | $64,926,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,069,000 | 1,660,000 | 2,744,000 | 2,696,000 | 2,042,000 |
| Accounts payable and accrued liabilities | 17,864,000 | 18,938,000 | 18,663,000 | 17,729,000 | 17,370,000 |
| Other current liabilities | 1,458,000 | 847,000 | 1,026,000 | 819,000 | 891,000 |
| TOTAL | $22,740,000 | $22,594,000 | $23,649,000 | $22,222,000 | $21,513,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,081,000 | 28,134,000 | 28,206,000 | 24,109,000 | 17,410,000 |
| Other Non-Current Liabilities | 7,465,000 | 9,141,000 | 9,053,000 | 8,690,000 | 8,733,000 |
| TOTAL | $41,174,000 | $43,482,000 | $43,660,000 | $35,726,000 | $28,967,000 |
| Total Liabilities | $63,914,000 | $66,076,000 | $67,309,000 | $57,948,000 | $50,480,000 |
| Shareholders' Equity | |||||
| Common Shares | 387,000 | 387,000 | 387,000 | 328,000 | 328,000 |
| Retained earnings | -1,228,000 | 1,710,000 | 2,200,000 | 5,335,000 | 4,089,000 |
| Other shareholders' equity | 2,069,000 | 2,064,000 | 2,207,000 | 2,050,000 | 2,053,000 |
| TOTAL | $36,359,000 | $39,287,000 | $39,912,000 | $15,693,000 | $14,446,000 |
| Total Liabilities And Equity | $100,273,000 | $105,363,000 | $107,221,000 | $73,641,000 | $64,926,000 |